Evotec SE (EVOTF) Cost of Revenue (2020 - 2025)
Evotec SE's (EVOTF) quarterly Cost of Revenue came in at $203474.8 in Q4 2025, up 8.75% year-on-year from $187111.1 in Q4 2024, and up 6.16% quarter-over-quarter from $191665.4 in Q3 2025.
Evotec SE (EVOTF) Cost of Revenue (2020 - 2025) Analysis & Trends
Evotec SE has disclosed Cost of Revenue across 6 years of filings, most recently posting $203474.8 for Q4 2025.
- Cost of Revenue for Q4 2025 came in at $203474.8, up 8.75% year-over-year; the trailing twelve-month figure through Dec 2025 was $765222.3 (down 24.9% YoY), and the FY2025 annual result was $784798.1, up 7.67% from the prior year.
- Cost of Revenue came in at $203474.8 for Q4 2025 at Evotec SE, up from $191665.4 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $476349.8 in Q4 2023 to a low of $123525.8 in Q1 2021.
- The 5-year median for Cost of Revenue is $172491.5 (2023), against an average of $213228.1.
- Peak annual rise in Cost of Revenue reached 26.06% in 2021, while the deepest fall reached 99.88% in 2021.
- Evotec SE's Cost of Revenue stood at $379219.5 in 2021, then climbed by 12.77% to $427636.7 in 2022, then gained by 11.39% to $476349.8 in 2023, then sank by 60.72% to $187111.1 in 2024, then climbed by 8.75% to $203474.8 in 2025.
- The last three Cost of Revenue figures came in at $203474.8 (Q4 2025), $191665.4 (Q3 2025), and $187111.1 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Evotec SE | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 203,474.81 |
| Dec 31, 2025 | 203,474.81 |
| Sep 30, 2025 | 191,665.41 |
| Sep 30, 2025 | 191,665.41 |
| Dec 31, 2024 | 187,111.05 |
| Dec 31, 2024 | 187,111.05 |
| Sep 30, 2024 | 182,971.06 |
| Sep 30, 2024 | 182,971.06 |
| Dec 31, 2023 | 476,349.80 |
| Dec 31, 2023 | 476,349.80 |
| Sep 30, 2023 | 172,491.52 |
| Sep 30, 2023 | 172,491.52 |
| Jun 30, 2023 | 134,978.71 |
| Jun 30, 2023 | 134,978.71 |
| Dec 31, 2022 | 427,636.68 |
| Dec 31, 2022 | 427,636.68 |
| Sep 30, 2022 | 146,667.62 |
| Sep 30, 2022 | 146,667.62 |
| Jun 30, 2022 | 150,783.65 |
| Jun 30, 2022 | 150,783.65 |